share_log

StockNews.com Downgrades Mettler-Toledo International (NYSE:MTD) to Buy

StockNews.com Downgrades Mettler-Toledo International (NYSE:MTD) to Buy

StockNews.com將梅特勒-託萊多國際公司(紐約證券交易所代碼:MTD)的評級下調至買入
Defense World ·  2022/09/24 02:11

Mettler-Toledo International (NYSE:MTD – Get Rating) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating in a report issued on Saturday.

在上週六發布的一份報告中,斯托克新聞網的分析師將梅特勒-託萊多國際公司(NYSE:MTD-GET)的評級從“強力買入”下調至“買入”。

Several other analysts also recently issued reports on the stock. Robert W. Baird upped their price target on shares of Mettler-Toledo International from $1,369.00 to $1,406.00 and gave the company a "neutral" rating in a report on Monday, August 1st. The Goldman Sachs Group reduced their price target on shares of Mettler-Toledo International from $1,280.00 to $1,140.00 and set a "sell" rating on the stock in a report on Thursday, July 14th. Stifel Nicolaus raised shares of Mettler-Toledo International from a "hold" rating to a "buy" rating and set a $1,500.00 price target on the stock in a report on Tuesday, September 6th. UBS Group started coverage on shares of Mettler-Toledo International in a research note on Wednesday, July 20th. They set a "neutral" rating and a $1,237.00 price objective on the stock. Finally, TheStreet downgraded shares of Mettler-Toledo International from a "b" rating to a "c+" rating in a research note on Thursday, July 28th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International has a consensus rating of "Hold" and a consensus price target of $1,338.60.

其他幾位分析師最近也發佈了有關該股的報告。在8月1日週一的一份報告中,羅伯特·W·貝爾德將梅特勒-託萊多國際公司的股票目標價從1,369.00美元上調至1,406.00美元,並給予該公司“中性”評級。在7月14日星期四的一份報告中,高盛夫婦將梅特勒-託萊多國際公司的股票目標價從1,280.00美元下調至1,140.00美元,並對該股設定了“賣出”評級。Stifel Nicolaus在9月6日星期二的一份報告中將梅特勒-託萊多國際公司的股票評級從持有上調至買入,併為該股設定了1,500.00美元的目標價。瑞銀集團在7月20日星期三的一份研究報告中開始對梅特勒-託萊多國際的股票進行報道。他們為該股設定了“中性”評級和1237.00美元的目標價。最後,華爾街在7月28日星期四的一份研究報告中將梅特勒-託萊多國際公司的股票評級從“b”下調至“c+”。一名股票研究分析師將該股評級為賣出,兩名分析師給予持有評級,三名分析師給予該股買入評級。根據MarketBeat.com的數據,梅特勒-託萊多國際公司的共識評級為持有,共識目標價為1,338.60美元。

Get
到達
Mettler-Toledo International
梅特勒-託萊多國際
alerts:
警報:

Mettler-Toledo International Trading Down 0.3 %

梅特勒-託萊多國際股價下跌0.3%

Shares of MTD opened at $1,132.01 on Friday. The company has a current ratio of 1.18, a quick ratio of 0.77 and a debt-to-equity ratio of 250.82. The firm's 50-day moving average is $1,267.94 and its two-hundred day moving average is $1,269.03. Mettler-Toledo International has a twelve month low of $1,082.78 and a twelve month high of $1,714.75. The firm has a market capitalization of $25.48 billion, a P/E ratio of 31.90, a PEG ratio of 2.86 and a beta of 1.14.

MTD股價上週五開盤報1,132.01美元。該公司的流動比率為1.18%,速動比率為0.77%,債務權益比率為250.82。該公司50日移動均線切入位在1,267.94美元,200日移動均線切入位在1,269.03美元。梅特勒-託萊多國際公司的股價為1,082.78美元的12個月低點和1,714.75美元的12個月高點。該公司市值為254.8億美元,市盈率為31.90倍,聚乙二醇率為2.86倍,貝塔係數為1.14。

Mettler-Toledo International (NYSE:MTD – Get Rating) last issued its earnings results on Friday, July 29th. The medical instruments supplier reported $9.39 earnings per share for the quarter, topping the consensus estimate of $8.78 by $0.61. Mettler-Toledo International had a net margin of 21.23% and a return on equity of 799.34%. The company had revenue of $978.39 million for the quarter, compared to analyst estimates of $951.81 million. During the same period in the prior year, the business posted $8.10 earnings per share. The firm's revenue for the quarter was up 5.8% compared to the same quarter last year. On average, research analysts predict that Mettler-Toledo International will post 38.99 earnings per share for the current fiscal year.
梅特勒-託萊多國際公司(紐約證券交易所代碼:MTD-GET評級)最近一次發佈收益報告是在7月29日星期五。這家醫療器械供應商公佈本季度每股收益為9.39美元,比普遍預期的8.78美元高出0.61美元。梅特勒-託萊多國際公司的淨利潤率為21.23%,股本回報率為799.34%。該公司本季度營收為9.7839億美元,而分析師預期為9.5181億美元。去年同期,該業務公佈的每股收益為8.10美元。與去年同期相比,該公司本季度的收入增長了5.8%。研究分析師平均預測,梅特勒-託萊多國際公司本財年每股收益將達到38.99美元。

Insider Buying and Selling

內幕買賣

In related news, CFO Shawn Vadala sold 800 shares of the company's stock in a transaction that occurred on Tuesday, August 2nd. The shares were sold at an average price of $1,344.06, for a total transaction of $1,075,248.00. Following the completion of the transaction, the chief financial officer now owns 4,900 shares of the company's stock, valued at $6,585,894. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CFO Shawn Vadala sold 800 shares of the company's stock in a transaction that occurred on Tuesday, August 2nd. The shares were sold at an average price of $1,344.06, for a total transaction of $1,075,248.00. Following the completion of the transaction, the chief financial officer now owns 4,900 shares of the company's stock, valued at $6,585,894. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Olivier A. Filliol sold 374 shares of the stock in a transaction on Friday, August 26th. The stock was sold at an average price of $1,314.05, for a total transaction of $491,454.70. Following the completion of the sale, the director now directly owns 30 shares of the company's stock, valued at approximately $39,421.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 20,440 shares of company stock valued at $27,465,861. Insiders own 2.80% of the company's stock.

在相關新聞中,首席財務官肖恩·瓦達拉在8月2日星期二的一筆交易中出售了800股該公司股票。這些股票的平均價格為1,344.06美元,總成交額為1,075,248.00美元。交易完成後,首席財務官現在擁有該公司4900股股票,價值6,585,894美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過美國證券交易委員會網站。在相關新聞中,首席財務官肖恩·瓦達拉在8月2日星期二的一筆交易中出售了800股該公司股票。這些股票的平均價格為1,344.06美元,總成交額為1,075,248.00美元。交易完成後,首席財務官現在擁有該公司4900股股票,價值6,585,894美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過美國證券交易委員會網站。此外,奧利維爾·A·費利奧爾在8月26日(星期五)的一次交易中出售了374股董事股票。該股的平均售價為1,314.05美元,總成交金額為491,454.70美元。出售完成後,董事現在直接擁有該公司30股股票,價值約39421.50美元。關於這次銷售的披露可以找到這裏。在上個季度,內部人士出售了20,440股公司股票,價值27,465,861美元。內部人士持有該公司2.80%的股份。

Institutional Investors Weigh In On Mettler-Toledo International

機構投資者參與梅特勒-託萊多國際

Large investors have recently made changes to their positions in the business. Stock Yards Bank & Trust Co. grew its holdings in Mettler-Toledo International by 1.5% during the 2nd quarter. Stock Yards Bank & Trust Co. now owns 533 shares of the medical instruments supplier's stock valued at $612,000 after purchasing an additional 8 shares in the last quarter. Eaton Vance Management grew its holdings in Mettler-Toledo International by 0.6% during the 4th quarter. Eaton Vance Management now owns 1,584 shares of the medical instruments supplier's stock valued at $1,965,000 after purchasing an additional 9 shares in the last quarter. Private Trust Co. NA grew its holdings in Mettler-Toledo International by 1.2% during the 2nd quarter. Private Trust Co. NA now owns 783 shares of the medical instruments supplier's stock valued at $899,000 after purchasing an additional 9 shares in the last quarter. Main Street Financial Solutions LLC grew its holdings in Mettler-Toledo International by 2.8% during the 1st quarter. Main Street Financial Solutions LLC now owns 365 shares of the medical instruments supplier's stock valued at $501,000 after purchasing an additional 10 shares in the last quarter. Finally, Personal CFO Solutions LLC grew its holdings in Mettler-Toledo International by 1.4% during the 1st quarter. Personal CFO Solutions LLC now owns 747 shares of the medical instruments supplier's stock valued at $1,026,000 after purchasing an additional 10 shares in the last quarter. Institutional investors and hedge funds own 93.00% of the company's stock.

大型投資者最近改變了他們在該業務中的頭寸。第二季度,Stock Yards Bank&Trust Co.對梅特勒-託萊多國際的持股增加了1.5%。Stock Yards Bank&Trust Co.在上個季度又購買了8股後,現在持有這家醫療器械供應商533股股票,價值61.2萬美元。伊頓·萬斯管理公司在第四季度增持了梅特勒-託萊多國際公司0.6%的股份。伊頓·萬斯管理公司在上個季度額外購買了9股後,現在擁有這家醫療器械供應商1,584股股票,價值1,965,000美元。私人信託公司NA在第二季度增持了1.2%的梅特勒-託萊多國際公司的股份。私人信託公司NA現在持有這家醫療器械供應商783股股票,價值89.9萬美元,此前該公司在上個季度又購買了9股。Main Street Financial Solutions LLC在第一季度增持了梅特勒-託萊多國際公司2.8%的股份。Main Street Financial Solutions LLC現在擁有這家醫療器械供應商365股股票,價值50.1萬美元,上個季度又購買了10股。最後,Personal CFO Solutions LLC在第一季度增持了1.4%的梅特勒-託萊多國際股份。Personal CFO Solutions LLC在上個季度又購買了10股後,現在擁有這家醫療器械供應商747股股票,價值1,026,000美元。機構投資者和對衝基金持有該公司93.00%的股票。

Mettler-Toledo International Company Profile

梅特勒-託萊多國際公司簡介

(Get Rating)

(獲取評級)

Mettler-Toledo International Inc engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

梅特勒-託萊多國際公司致力於在全球範圍內製造和供應精密儀器和服務。它分為五個部門:美國業務、瑞士業務、西歐業務、中國業務和其他業務。該公司的實驗室儀器包括實驗室天平、液體移液、自動化實驗室反應器、滴定儀、pH計、過程分析傳感器和分析技術、物理值分析儀、熱分析系統和其他分析儀器;以及LABX,這是一個管理和分析其儀器產生的數據的實驗室軟件平臺。

Read More

閲讀更多內容

  • Get a free copy of the StockNews.com research report on Mettler-Toledo International (MTD)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • 2 Semiconductor Stocks To Watch For Reversals
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • Will Crowdstrike Get A Boost From Increased EPS Guidance?
  • 免費獲取StockNews.com關於梅特勒-託萊多國際公司(MTD)的研究報告
  • MarketBeat:回顧一週9/19-9/23
  • 為什麼特斯拉的股票保持彈性?
  • 需要關注的2只半導體類股走勢逆轉
  • 小盤股的裁員是樓市的晴雨表嗎?
  • CrowdStrike是否會從增加每股收益指引中獲得提振?

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.

接受梅特勒-託萊多國際日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對梅特勒-託萊多國際公司和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論